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ABSTRACTSwiring. We found no correlation between glove perforation and sternal
wound infection.
0153: DOES EXPLORATIVE THORACOTOMY FOR NON-SMALL CELL LUNG
CANCER (NSCLC) ADVERSELY AFFECT PATIENTS’ OUTCOME
POSTOPERATIVELY?
James Rigby, Aiman Alzetani, Adam Lea, Shilajit Ghosh. University Hospital
of North Staffordshire, Stoke-on-Trent, UK
Aims: To determine our incidence of explorative thoracotomy for NSCLC
and its inﬂuence on further management of patients & their survival.
Methods: Retrospective review of patients referred for lung cancer surgery
over 2.5 years. Clinical data were collected on radiological/pathological
staging and post-operative management including survival status.
Results: Between January 2008-August 2011, 418 patients underwent
thoracotomy for primary lung cancer, of which 27 patients (6%) had
inoperable disease. Of the inoperable cases, 4 (15%) had a pre-explorative
mediastinoscopy and 22 (81%) were investigated with PET studies.
Sixteen patients (59%) had radiological-advanced stage (IIIA-). Inoper-
ability was due to stage migration, N2 disease, tumour invasion or poor
physiological status intra-operatively.
Subsequent treatments included adjuvant (chemotherapy/ radiotherapy
/combined) in 16 patients (59%) of which 12 (75%) are still alive with an
average length of survival of 9 months.
Conclusion: Our incidence of explorative thoracotomy is well within those
reported in the literature. Over half of patients were still suitable for radical
adjuvant treatment and 44% survived for an average 9 months post-
surgery.
Surgery should not be denied for advanced NSCLC to avoid depriving
patients the beneﬁt of curative resection and if resection cannot be ach-
ieved then some patients are suitable for adjuvant treatments.
0308: THE USE OF HOMOGRAFTS IN THE OPERATIVE MANAGEMENT OF
INFECTIVE ENDOCARDITIS HAS LOWER SHORT AND MEDIUM-TERM
MORTALITY AND IMPROVED OVERALL OUTCOME COMPARED TO
PROSTHETIC VALVES
Abderahman Kamaledeen 1, Rizwan Q. Attia 2, James C.
Roxburgh 2, Christopher P. Young 2, Christopher I. Blauth 2. 1King's
College London, London, UK; 2Department of Cardiothoracic Surgery, St
Thomas' Hospital, London, UK
Aim: Infective endocarditis remains a challenging clinical entity, particu-
larly with changing causative organisms. We aim to characterize the
operative management, microbiology, operative mortality and long-term
survival in a contemporary cohort of patients having surgery for IE.
Methods: We reviewed the records of 125 consecutive patients who had
surgery for IE over ﬁve years (2006-2011), at a large tertiary cardiovascular
centre. The valve prosthesis, causative organism, in-hospital morality,
long-term survival and need for repeat surgery were examined.
Results: Cumulative Kaplan-Meier survival was 86.8% at one-year and
67.8% at ﬁve years. 101/125(80.8%) patients had isolated valve surgery, 13/
125(13.6%) two valves and 7/125(5.6%) three valves. Of the aortic valve IE,
24/66(36.3%) patients had aortic homograft (LES 44.7%), 33/66(50%) had
tissue valve (LES47.7%) and 9/66(13.6%) mechanical prosthesis (LES 23.3%).
The use of Homograft as a valve substitute was more common in patients
with annular involvement and intracardiac abscesses. In-hospital
mortality for homograft was 4.5% vs. 8% for prosthetic valve p0.01. There
were no re-infections in the homograft group vs. 4.5% for prosthetic valve
p0.001.
Conclusion: In patients having operation for infective endocarditis,
homograft valve replacement provided excellent short and medium-term
outcomes with superior survival and freedom from re-intervention
compared with prosthetic valve replacement
0380: THE ROLE OF SURGICAL LUNG BIOPSY IN THE MANAGEMENT OF
UNDEFINED PARENCHYMAL LUNG DISEASE
Vivienne Blackhall, Felice Granato, Katrina Knight, Bernadette Quinn, Ali
Jilaihaiwi, Alan Kirk, Mohammed Asif. Golden Jubilee National Hospital,
Glasgow, UK
Aim: To examine whether surgical lung biopsy (SLB) is worthwhile in the
diagnosis of undeﬁned parenchymal lung disease (UPLD).Methods: 113 patients over a two year period at a single institution
underwent SLB for UPLD. Patient demographics, pre-operative diagnosis
and treatment, surgical approach, number and site of biopsies, complica-
tions, length of postoperative stay and postoperative diagnosis and treat-
ment were examined.
Results: Fifty six patients were female and 57 were male. The median age
was 59 years. Following biopsy, 27% of patients received no clear patho-
logical diagnosis and 73% received a speciﬁc diagnosis. Of all patients, 42%
had a change in their treatment following the procedure. We observed 5
(4%) perioperative deaths, 7 major complications (6%) and 8 minor
complications (8%). The median hospital stay was 4 days.
Conclusions: Surgical lung biopsy is a relatively safe procedure. Although
it provides an accurate diagnosis for many patients, SLB can be inconclu-
sive and can fail to provide a consistent change in patient management. It
can be associated with a prolonged post-operative stay, resulting in an
increased cost to the NHS. SLB should therefore be performed in a select
group of patients with UPLD after discussion at a respiratory multidisci-
plinary team meeting.
0513: WHAT'S THE ROLE OF VENTRICULAR ENDOCARDIAL
RECONSTRUCTION SURGERY IN 2011? A SINGLE CENTRE 7 YEAR
EXPERIENCE
Rizwan Attia, Hannah Fleming, John Chambers, Fikrat Shabbo. Guys and
Saint Thomas', London, UK
Aim: Surgical ventricular restoration in patients with coronary artery
disease, post infarction left ventricular aneurysm or ischemic dilated
cardiomyopathy is a viable treatment option,yet conﬂicting data currently
exists. We evaluated the 7-year clinical experience of this procedure in our
institution.
Methods: From 2003 to 2010, surgical ventricular restoration was per-
formed in 86 patients (M2.3:1F), mean age 64.5 years. All patients pre-
sented with angina, heart failure and/or ventricular tachycardia.
Post-infarction left ventricular aneurysm was present in all patients and
ischemic dilated cardiomyopathy with a large akinetic left ventricle in
11.6%. The preoperative left ventricular ejection fraction was 33.110 %.
Multi-vessel disease was present in 93% patients.
Results: All patients underwent endoventricular or circular patch repair.
94% had concomitant coronary revascularisation, median of 2 grafts and 5%
had mitral valve repair. Intra-aortic balloon pump was placed pre-opera-
tively in 18.6% while 16.2% needed inotropic support for more than 24h.
Postoperative stroke occurred in 1 patient. In-hospital mortality was 4.6%.
All cause cardiovascular mortality at ﬁve years was 8.1%. Mean follow-up in
operative survivors was 4.42.8years. Actuarial survival at 1,2 and 5 years
was 90.6%, 87.9% and 79.1%.
Conclusions: Early and long-term results are good in terms of survival and
better when compared to ventricular resynchronisation therapy and
medical management.
0567: A FIVE YEAR AUDIT STUDY ON DEEP STERNAL WOUND
INFECTIONS AND ASSOCIATED DEHISCENCE POST MEDIAN
STERNOTOMY: AN ANALYSIS OF PATIENT OUTCOME, RISK FACTORS
AND A PROPOSED MANAGEMENT STRATEGY
Kenneth Porter 1, Rujuta Roplekar 2, Pari Mohanna 1. 1 St Thomas' Hospital,
London, UK; 2King's College Hospital, London, UK
Aims: To audit risk factors, outcome and management of patients who
developed post median sternotomy wound infections and associated
dehiscence.
Methods: In a ﬁve year retrospective study 6335 consecutive patients who
underwent median sternotomies for coronary artery bypass grafts and
aortic valve replacements were examined.
Results: There were 166 sternal wound infections (2.6%). 48 patients
(0.76%) underwent treatments such as vacuum therapy and debridements
for sternal dehiscence. Increased age, BMI, a lower ejection fraction and
diabetes were risk factors for developing sternal wound infections
requiring more radical treatments.
18 patients required sternal reconstruction in the form of a ﬂap and on
average were seen by plastic surgeons 13 days after the onset of dehis-
cence. In the reconstruction group each patient received on average 27
days of vacuum therapy and 3 debridements.
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ABSTRACTSConclusions: All patients should be risk stratiﬁed for post median ster-
notomy wound infections.
In patients with signiﬁcant risk factors and infected sternal wound
dehiscence combined plastic and cardiothoracic surgical input should be
undertaken from the outset.
Aggressive and early one stage debridement and ﬂap coverage should be
considered in serious sternal wound infections associated with dehiscence
as it may negate the need for multiple debridements and prolonged
vacuum therapy.
0614: SYNCHRONOUS CAROTID ENDARTERECTOMY FOR
ASYMPTOMATIC CAROTID STENOSIS AND CORONARY ARTERY BYPASS
GRAFTING IN PATIENTS WITH CONCOMITANT DISEASE - A
LITERATURE REVIEW
Frances Burrell. Glasgow Royal Inﬁrmary, Glasgow, UK
Aims: This literature review investigates the outcomes of synchronous
coronary artery bypass grafting (CABG) and carotid endarterectomy
(CEA) for concomitant disease in neurologically asymptomatic
patients.
Methods: An electronic OVID Medline database search using the
following criteria: "asymptomatic", "carotid stenosis", "carotid endarter-
ectomy", "CEA", "coronary artery bypass", "CABG" gave a total of 56 arti-
cles. Stroke and mortality rates were calculated and compared to CABG
alone in patients with carotid stenosis. Fishers exact test was used to
calculate signiﬁcance.
Results: Incidence of stroke was signiﬁcantly less in asymptomatic
patients undergoing synchronous surgery compared to symptomatic
patients, 1.7% versus 13.2%, risk 0.13 (95%conﬁdence interval 0.08-0.21,
P¼<0.0001). There was a small signiﬁcant decrease in stroke risk in
patients undergoing synchronous surgery compared to CABG alone, 3.4%
versus 5.8% , risk 0.92 (CI¼ 0.86-0.99, P¼0.0123), but this was insigniﬁcant
when limited to asymptomatic patients. There was a trend of increased
mortality in symptomatic patients and in synchronous surgery which was
not statistically signiﬁcant.
Conclusions: This study suggests synchronous surgery decreases stroke
risk in patients with carotid stenosis compared to CABG alone, but
mortality beneﬁt and beneﬁt to asymptomatic patients remains unclear.
Neurologically symptomatic patients have worse outcomes compared to
those with asymptomatic carotid stenosis.
0892: WEIGHT REDUCTION PRIOR TO ELECTIVE CORONARY
REVASCULARIZATION IN EXTREMELY OBESE PATIENTS IMPROVES
CLINICAL OUTCOMES
Remananda K. Pai, Natasha Prior, Christopher M.R. Satur. University
Hospital North Staffordshire, Stoke on Trent, UK
Introduction: 20% of patients undergoing coronary revascularization
[CABG] in the UK are obese, with associated co-morbidities including
diabetes, hypercholesterolemia poor mobility, and smoking. They present
a high risk for CABG. We examined the impact of diligent preoperative risk
modiﬁcation on postoperative outcomes.
Methods: We instituted a closely monitored regimen of risk reduction
focusing on weight loss, cessation of smoking and diabetic control, in
extremely obese patients [BMI>40] requiring elective CABG [Group WL]
and examined their outcome compared to less obese patients outside the
study group [Group OE]. Kruskal Wallis and Anova method was used for
statistical analysis.
Results: A 8.9% weight loss was achieved safely in the 13 patients [Group
WL] over 202 days, with a fall in BMI from 43.9 [+ 3.7] to 40.1[+3.4]. Four
patients quit smoking and tight glycemic control was achieved in 8 dia-
betics before surgery. In spite of the poorer patient proﬁle, patients in
group WL did better with lower incidence of mediastinitis, wound infec-
tion, early mobilization and hospital stay compared to Group OE.
Conclusion: Weight loss was safely achieved in extremely obese patients
before planned CABG with tangible reduction of adverse postoperative
outcomes and promises a better result in this high risk cohort of patients.
0983: THE OUTCOME OF CARDIAC SURGERY IN OCTOGENARIANS: A 13
YEAR EXPERIENCE
Ghazi Elshaﬁe, Omar Nawaytou, Taha Binesmael, Ana Lopez, Dheeraj
Mehta. University Hospital of Wales, Cardiff, UKAim: Advanced age is associated with increased risk in cardiac surgery
and more octogenarians are being referred for interventional procedures
for structural and ischemic heart disease. The aim of this study is to
evaluate our surgical outcome in octogenarians following cardiac
surgery.
Methods: Between January 1998 and May 2011, we identiﬁed 530 octo-
genarians who underwent cardiac surgery. The mean age was 82.3 +/- 2.4
years with a logistic EuroSCORE of 16.39 +/- 14.63. 135 patients (25.5%)
underwent isolated coronary artery bypass grafting (CABG), 357 patients
(67.3%) had aortic or mitral valve procedures.
Results: The in-hospital mortality was 6.0%. Major complications included
stroke in 0.8%, new haemoﬁlteration in 9.1% and permanent pace maker
insertion in 5.8% of patients respectively. Median postoperative staywas 13
days. The overall actuarial survival at 1, 3 and 5 years was 87.4%, 80.0% and
75.2% respectively. The actuarial survival at 5 years for the isolated CABG
group, aortic valve replacement group and mitral valve group was 82.8%,
74.7% and 74.0% respectively.
Conclusion: In our experience, cardiac surgery in octogenarians has
excellent early and long-term survival. Morbidity rates are acceptable. We
conclude that cardiac surgery should not be discounted in octogenarians
on the basis of age alone.
1004: CORONARY ARTERY BYPASS GRAFTING ON DIALYSIS-DEPENDENT
CHRONIC RENAL FAILURE PATIENTS: SHORT AND LONG-TERM
OUTCOMES, A 12 YEAR EXPERIENCE
Ghazi Elshaﬁe, Omar Nawaytou, Taha Binesmael, Ana Lopez, Dheeraj
Mehta. University Hospital of Wales, Cardiff, UK
Aim: Performing coronary artery bypass graft surgery (CABG) on dialysis-
dependent end-stage renal disease patients is still a subject for debate. This
study focuses on the short and long term outcomes of dialysis-dependent
patients undergoing CABG.
Methods: Between October 1998 and December 2010, we identiﬁed 65
dialysis dependent patients who underwent CABG in our institution. The
mean logistic EuroSCORE was 17.07 +/- 20.62. 38 patients (58.5%) under-
went isolated CABG and 27 patients (41.5%) had concomitant procedures.
Results: The total in-hospital mortality was 7.7%. Major complications
included reintubation in 4.6% of patients. None of the patients had new
post-operative stroke. The median postoperative stay was 14 days. The
overall actuarial survival at 1, 3 and 5 years was 80.0%, 64.3% and 49.8%
respectively. The actuarial survival at 5 years for the isolated CABG group,
aortic valve replacement group and mitral valve group was 51.8%, 52.5%
and 40.4% respectively.
Conclusion: Cardiac surgery can be performed in end stage renal disease
with acceptable morbidity and mortality. The relatively decreased long
term survival is only a reﬂection of their high natural attrition state and
cardiac surgery should not be discounted solely on this foundation.
1065: ANTIPLATELET THERAPY FOLLOWING CORONARY ARTERY
BYPASS GRAFT SURGERY
Amir Sepehripour, Nikolaos Koumallos. Wythenshawe Hospital,
Manchester, UK
Aim: The most recent American College of Cardiology Foundation/Amer-
ican Heart Association guidelines for coronary artery bypass graft surgery
(CABG) recommend the initiation of Aspirin (100-325mg) within 6-hours
post-operatively and indeﬁnite continuation, supported by class 1A
evidence. This study aimed to evaluate adherence to these guidelines in
our cardiac unit.
Method: A retrospective analysis of 100 consecutive patients undergoing
CABG was conducted, analysing antiplatelet agents, dosing and timing
of administration. The ﬁndings and recommendations were presented
at local level. A prospective analysis of a further 100 consecutive
patients undergoing CABG was conducted, analysing the above primary
outcomes.
Results: The retrospective analysis revealed the following therapies:
Aspirin 75mg-73%, Clopidogrel 75mg-5%, Aspirin+Clopidogrel 75mg-15%
and Aspirin 300mg-7%. Initiation of therapy within 6-hours was not
observed in any patient. The prospective analysis revealed the following
therapies: Aspirin 75mg-61%, Clopidogrel 75mg-4%, Aspirin+Clopidogrel
75mg-7% and Aspirin 300mg-28%. Initiation of therapywithin 6-hours was
observed in 16%.
